| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | $0.0B | $0.0B | $0.0B | — | — | — |
| Cost of Revenue | — | — | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — | — | — |
| R&D Expense | — | — | — | — | — | — | — | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | — | — | — | — | — | — | — | — |
| Net Income | $0.2B | $0.2B | $0.2B | $0.2B | $0.1B | $0.1B | $0.1B | $0.1B |
| EPS (Basic) | $4.60 | $4.25 | $3.85 | $3.46 | $2.85 | $1.32 | $0.92 | $1.59 |
| EPS (Diluted) | $4.58 | $4.23 | $3.83 | $3.44 | $2.81 | $1.32 | $0.92 | $1.52 |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $12.5B | $11.5B | $11.3B | $9.8B | $9.9B | $9.8B | $9.3B | $6.6B |
| Current Assets | — | — | — | — | — | — | — | — |
| Cash & Equivalents | $1.0B | $0.6B | $0.7B | $0.6B | $2.0B | $2.2B | $0.9B | $0.4B |
| Total Liabilities | $11.1B | $10.2B | $10.2B | $8.8B | $8.8B | $8.7B | $8.3B | $5.6B |
| Current Liabilities | — | — | — | — | — | — | — | — |
| Stockholders' Equity | $1.4B | $1.3B | $1.2B | $1.0B | $1.1B | $1.1B | $1.0B | $1.0B |
| Metric | FY 2025↕ | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $0.2B | $0.3B | $0.3B | $0.2B | $0.1B | $-0.1B | $0.1B | $0.1B |
| Investing Cash Flow | $-0.4B | $-0.3B | $-1.4B | $-1.5B | $-0.2B | $0.9B | $0.8B | $-0.5B |
| Capital Expenditures | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| Financing Cash Flow | $0.7B | $-0.1B | $1.3B | $-0.1B | $-0.0B | $0.5B | $-0.5B | $0.3B |